Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rehg, JE; Blackman, MA; Toth, LA
   Persistent transmission of mouse hepatitis virus by transgenic mice
   COMPARATIVE MEDICINE
   
   J.E. Rehg et al., "Persistent transmission of mouse hepatitis virus by transgenic mice", COMPAR MED, 51(4), 2001, pp. 369-374
2. Kragh, M; Quistorff, B; Lund, EL; Kristjansen, PEG
   Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy
   NEOPLASIA
   
   M. Kragh et al., "Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy", NEOPLASIA, 3(4), 2001, pp. 324-330
3. Bhujwalla, ZM; Artemov, D; Natarajan, K; Ackerstaff, E; Solaiyappan, M
   Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts
   NEOPLASIA
   
   Z.M. Bhujwalla et al., "Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts", NEOPLASIA, 3(2), 2001, pp. 143-153
4. Ozawa, S; Shinohara, H; Kanayama, H; Bruns, CJ; Bucana, CD; Ellis, LM; Davis, DW; Fidler, IJ
   Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha
   NEOPLASIA
   
   S. Ozawa et al., "Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha", NEOPLASIA, 3(2), 2001, pp. 154-164
5. Pedersen, MWB; Holm, S; Lund, EL; Hojgaard, L; Kristjansen, PEG
   Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro
   NEOPLASIA
   
   M.W.B. Pedersen et al., "Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro", NEOPLASIA, 3(1), 2001, pp. 80-87
6. Wang, XL; Dao, MA; Kuo, I; Nolta, JA
   Phenotypic comparison of extrathymic human bone-marrow-derived T cells with thymic-selected T cells recovered from different tissues
   CLINICAL IMMUNOLOGY
   
   X.L. Wang et al., "Phenotypic comparison of extrathymic human bone-marrow-derived T cells with thymic-selected T cells recovered from different tissues", CLIN IMMUNO, 100(3), 2001, pp. 339-348
7. Smyth, MJ; Trapani, JA
   Lymphocyte-mediated immunosurveillance of epithelial cancers?
   TRENDS IN IMMUNOLOGY
   
   M.J. Smyth e J.A. Trapani, "Lymphocyte-mediated immunosurveillance of epithelial cancers?", TRENDS IMMU, 22(8), 2001, pp. 409-411
8. Herbst, RS; Kim, ES; Harari, PM
   IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   R.S. Herbst et al., "IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer", EXPERT OP B, 1(4), 2001, pp. 719-732
9. Lecuru, F; Agostini, A; Camatte, S; Robin, F; Aggerbeck, M; Jais, JP; Vilde, F; Taurelle, R
   Impact of pneumoperitoneum on visceral metastasis rate and survival. Results in two ovarian cancer models in rats
   BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
   
   F. Lecuru et al., "Impact of pneumoperitoneum on visceral metastasis rate and survival. Results in two ovarian cancer models in rats", BR J OBST G, 108(7), 2001, pp. 733-737
10. Romaneehsen, B; Anders, M; Rohrl, B; Hast, HJ; Hengstler, JG; Schiffer, I; Neugebauer, B; Teichmann, E; Schreiber, WG; Thelen, M
    Cryotherapy of malignant tumors. MR imaging in comparison with pathological changes in mice
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    B. Romaneehsen et al., "Cryotherapy of malignant tumors. MR imaging in comparison with pathological changes in mice", ROFO-F RONT, 173(7), 2001, pp. 632-638
11. Si, ZY; Tuch, BE; Walsh, DA
    Development of human fetal pancreas after transplantation into SCID mice
    CELLS TISSUES ORGANS
    
    Z.Y. Si et al., "Development of human fetal pancreas after transplantation into SCID mice", CELLS T ORG, 168(3), 2001, pp. 147-157
12. Humphrey, RK; Smith, MS; Kwok, J; Si, Z; Tuch, BE; Simpson, AM
    In vitro dedifferentiation of fetal porcine pancreatic tissue prior to transplantation as islet-like cell clusters
    CELLS TISSUES ORGANS
    
    R.K. Humphrey et al., "In vitro dedifferentiation of fetal porcine pancreatic tissue prior to transplantation as islet-like cell clusters", CELLS T ORG, 168(3), 2001, pp. 158-169
13. Sepp-Lorenzino, L; Tjaden, G; Moasser, MM; Timaul, N; Ma, Z; Kohl, NE; Gibbs, JB; Oliff, A; Rosen, N; Scher, HI
    Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer
    PROSTATE CANCER AND PROSTATIC DISEASES
    
    L. Sepp-Lorenzino et al., "Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer", PROSTATE C, 4(1), 2001, pp. 33-43
14. Damen, EWP; de Groot, FMH; Scheeren, HW
    Novel anthracycline prodrugs
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    E.W.P. Damen et al., "Novel anthracycline prodrugs", EXPERT OP T, 11(4), 2001, pp. 651-666
15. Mendelsohn, J
    The epidermal growth factor receptor as a target for cancer therapy
    ENDOCRINE-RELATED CANCER
    
    J. Mendelsohn, "The epidermal growth factor receptor as a target for cancer therapy", ENDOCR-R CA, 8(1), 2001, pp. 3-9
16. Sundberg, JP; King, LE; Bascom, C
    Animal models for male pattern (androgenetic) alopecia
    EUROPEAN JOURNAL OF DERMATOLOGY
    
    J.P. Sundberg et al., "Animal models for male pattern (androgenetic) alopecia", EUR J DERM, 11(4), 2001, pp. 321-325
17. Paule, B
    Interleukin-6 and bone metastases in renal cancer: molecular bases and therapeutic implications.
    PROGRES EN UROLOGIE
    
    B. Paule, "Interleukin-6 and bone metastases in renal cancer: molecular bases and therapeutic implications.", PROG UROL, 11(2), 2001, pp. 368-375
18. Kuroiwa, M; Ikeda, H; Hongo, T; Tsuchida, Y; Hirato, J; Kaneko, Y; Suzuki, N; Obana, K; Makino, SI
    Effects of recombinant human endostatin on a human neuroblastoma xenograft
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    M. Kuroiwa et al., "Effects of recombinant human endostatin on a human neuroblastoma xenograft", INT J MOL M, 8(4), 2001, pp. 391-396
19. Chen, QR; Zhang, L; Gasper, W; Mixson, AJ
    Targeting tumor angiogenesis with gene therapy
    MOLECULAR GENETICS AND METABOLISM
    
    Q.R. Chen et al., "Targeting tumor angiogenesis with gene therapy", MOL GEN MET, 74(1-2), 2001, pp. 120-127
20. Han, XG; Tuch, BE
    Cloning and characterization of porcine insulin gene
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    
    X.G. Han e B.E. Tuch, "Cloning and characterization of porcine insulin gene", COMP BIOC B, 129(1), 2001, pp. 87-95
21. Kramer, G; Steiner, GE; Sokol, P; Handisurya, A; Klingler, HC; Maier, U; Foldy, M; Marberger, M
    Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    G. Kramer et al., "Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer", J INTERF CY, 21(7), 2001, pp. 475-484
22. Nicoletti, MI; Valoti, G; Giannakakou, P; Zhan, ZR; Kim, JH; Lucchini, V; Landoni, F; Mayo, JG; Giavazzi, R; Fojo, T
    Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen: Correlation with sensitivity to microtubule active agents
    CLINICAL CANCER RESEARCH
    
    M.I. Nicoletti et al., "Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen: Correlation with sensitivity to microtubule active agents", CLIN CANC R, 7(9), 2001, pp. 2912-2922
23. Straub, B; Muller, M; Krause, H; Schrader, M; Goessl, C; Heicappell, R; Miller, K
    Increased incidence of luteinizing hormone-releasing hormone receptor genemessenger RNA expression in hormone-refractory human prostate cancers
    CLINICAL CANCER RESEARCH
    
    B. Straub et al., "Increased incidence of luteinizing hormone-releasing hormone receptor genemessenger RNA expression in hormone-refractory human prostate cancers", CLIN CANC R, 7(8), 2001, pp. 2340-2343
24. Solorzano, CC; Baker, CH; Tsan, R; Traxler, P; Cohen, P; Buchdunger, E; Killion, JJ; Fidler, IJ
    Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma
    CLINICAL CANCER RESEARCH
    
    C.C. Solorzano et al., "Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma", CLIN CANC R, 7(8), 2001, pp. 2563-2572
25. Guilbaud, N; Kraus-Berthier, L; Meyer-Losic, F; Malivet, V; Chacun, C; Jan, M; Tillequin, F; Michel, S; Koch, M; Pfeiffer, B; Atassi, G; Hickman, J; Pierre, A
    Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors
    CLINICAL CANCER RESEARCH
    
    N. Guilbaud et al., "Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors", CLIN CANC R, 7(8), 2001, pp. 2573-2580
26. Shan, SQ; Lockhart, AC; Saito, WY; Knapp, AM; Laderoute, KR; Dewhirst, MW
    The novel tubulin-binding drug BTO-956 inhibits R3230Ac mammary carcinoma growth and angiogenesis in Fischer 344 rats
    CLINICAL CANCER RESEARCH
    
    S.Q. Shan et al., "The novel tubulin-binding drug BTO-956 inhibits R3230Ac mammary carcinoma growth and angiogenesis in Fischer 344 rats", CLIN CANC R, 7(8), 2001, pp. 2590-2596
27. Hardman, WE; Avula, CPR; Fernandes, G; Cameron, IL
    Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts
    CLINICAL CANCER RESEARCH
    
    W.E. Hardman et al., "Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts", CLIN CANC R, 7(7), 2001, pp. 2041-2049
28. Ochakovskaya, R; Osorio, L; Goldenberg, DM; Mattes, MJ
    Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium
    CLINICAL CANCER RESEARCH
    
    R. Ochakovskaya et al., "Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium", CLIN CANC R, 7(6), 2001, pp. 1505-1510
29. Zhong, Y; Delgado, Y; Gomez, J; Lee, SW; Perez-Soler, R
    Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity
    CLINICAL CANCER RESEARCH
    
    Y. Zhong et al., "Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity", CLIN CANC R, 7(6), 2001, pp. 1683-1687
30. Gutowski, M; Carcenac, M; Pourquier, D; Larroque, C; Saint-Aubert, B; Rouanet, P; Pelegrin, A
    Intraoperative immunophotodetection for radical resection of cancers: Evaluation in an experimental model
    CLINICAL CANCER RESEARCH
    
    M. Gutowski et al., "Intraoperative immunophotodetection for radical resection of cancers: Evaluation in an experimental model", CLIN CANC R, 7(5), 2001, pp. 1142-1148
31. Ciardiello, F; Caputo, R; Bianco, R; Damiano, V; Fentanini, G; Cuccato, S; De Placido, S; Bianco, AR; Tortora, G
    Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor
    CLINICAL CANCER RESEARCH
    
    F. Ciardiello et al., "Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor", CLIN CANC R, 7(5), 2001, pp. 1459-1465
32. Shusterman, S; Grupp, SA; Barr, R; Carpentieri, D; Zhao, HQ; Maris, JM
    The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease
    CLINICAL CANCER RESEARCH
    
    S. Shusterman et al., "The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease", CLIN CANC R, 7(4), 2001, pp. 977-984
33. Tahtis, K; Lee, FT; Smyth, FE; Power, BE; Renner, C; Brechbiel, MW; Old, LJ; Hudson, PJ; Scott, AM
    Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model
    CLINICAL CANCER RESEARCH
    
    K. Tahtis et al., "Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model", CLIN CANC R, 7(4), 2001, pp. 1061-1072
34. Small, LA; Da Silva, DM; de Visser, KE; Velders, MP; Fisher, SG; Potkul, RK; Kast, WM
    A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy
    CLINICAL CANCER RESEARCH
    
    L.A. Small et al., "A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy", CLIN CANC R, 7(3), 2001, pp. 876S-881S
35. Honjo, Y; Nangia-Makker, P; Inohara, H; Raz, A
    Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells
    CLINICAL CANCER RESEARCH
    
    Y. Honjo et al., "Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells", CLIN CANC R, 7(3), 2001, pp. 661-668
36. Olson, KA; Byers, HR; Key, ME; Fett, JW
    Prevention of human prostate tumor metastasis in athymic mice by antisensetargeting of human angiogenin
    CLINICAL CANCER RESEARCH
    
    K.A. Olson et al., "Prevention of human prostate tumor metastasis in athymic mice by antisensetargeting of human angiogenin", CLIN CANC R, 7(11), 2001, pp. 3598-3605
37. Ciardiello, F; Tortora, G
    A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptor
    CLINICAL CANCER RESEARCH
    
    F. Ciardiello e G. Tortora, "A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptor", CLIN CANC R, 7(10), 2001, pp. 2958-2970
38. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
    Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks
    CLINICAL CANCER RESEARCH
    
    H. Minami et al., "Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks", CLIN CANC R, 7(10), 2001, pp. 3056-3064
39. Clive, S; Webb, DJ; MacLellan, A; Young, A; Byrne, B; Robson, L; Smyth, JF; Jodrell, DI
    Forearm blood flow and local responses to peptide vasodilators: A novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist
    CLINICAL CANCER RESEARCH
    
    S. Clive et al., "Forearm blood flow and local responses to peptide vasodilators: A novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist", CLIN CANC R, 7(10), 2001, pp. 3071-3078
40. Greenberger, LM; Annable, T; Collins, KI; Komm, BS; Lyttle, CR; Miller, CP; Satyaswaroop, PG; Zhang, YX; Frost, P
    A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats
    CLINICAL CANCER RESEARCH
    
    L.M. Greenberger et al., "A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats", CLIN CANC R, 7(10), 2001, pp. 3166-3177
41. Cardillo, TM; Ying, ZL; Gold, DV
    Therapeutic advantage of (90)Yttrium-versus (131)Iodine-labeled PAM4 antibody in experimental pancreatic cancer
    CLINICAL CANCER RESEARCH
    
    T.M. Cardillo et al., "Therapeutic advantage of (90)Yttrium-versus (131)Iodine-labeled PAM4 antibody in experimental pancreatic cancer", CLIN CANC R, 7(10), 2001, pp. 3186-3192
42. Guichard, S; Montazeri, A; Chatelut, E; Hennebelle, I; Bugat, R; Canal, P
    Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation
    CLINICAL CANCER RESEARCH
    
    S. Guichard et al., "Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation", CLIN CANC R, 7(10), 2001, pp. 3222-3228
43. Li, AH; Varney, ML; Singh, RK
    Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials
    CLINICAL CANCER RESEARCH
    
    A.H. Li et al., "Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials", CLIN CANC R, 7(10), 2001, pp. 3298-3304
44. Blaney, S; Berg, SL; Pratt, C; Weitman, S; Sullivan, J; Luchtman-Jones, L; Bernstein, M
    A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study
    CLINICAL CANCER RESEARCH
    
    S. Blaney et al., "A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study", CLIN CANC R, 7(1), 2001, pp. 32-37
45. Goel, A; Augustine, S; Baranowska-Kortylewicz, J; Colcher, D; Booth, BJM; Pavlinkova, G; Tempero, M; Batra, SK
    Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)
    CLINICAL CANCER RESEARCH
    
    A. Goel et al., "Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)", CLIN CANC R, 7(1), 2001, pp. 175-184
46. Cameron, DF; Hushen, JJ; Nazian, SJ
    Formation of insulin-secreting, Sertoli-enriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    
    D.F. Cameron et al., "Formation of insulin-secreting, Sertoli-enriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells", IN VITRO-AN, 37(8), 2001, pp. 490-498
47. Adam, RM; Orsola, A; Freeman, MR
    A novel method for implantation of LNCaP prostate tumor cells under the renal capsule
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    
    R.M. Adam et al., "A novel method for implantation of LNCaP prostate tumor cells under the renal capsule", IN VITRO-AN, 37(6), 2001, pp. 360-362
48. Gil-Benso, R; Martinez-Lorente, A; Pellin-Perez, A; Navarro-Fos, S; Gregori-Romero, MA; Carda, C; Callaghan, R; Peydro-Olaya, A; Llombart-Bosch, A
    Characterization of a new rat cell line established from 2 ' AAF-induced combined hepatocellular cholangiocellular carcinoma
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    
    R. Gil-Benso et al., "Characterization of a new rat cell line established from 2 ' AAF-induced combined hepatocellular cholangiocellular carcinoma", IN VITRO-AN, 37(1), 2001, pp. 17-25
49. Mai, KT; Yazdi, HM; Rippstein, P
    Light and electron microscopy of the pagetoid spread of germ cell carcinoma in the rete testis: Morphologic evidence suggestive of field effect as a mechanism of tumor spread
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    K.T. Mai et al., "Light and electron microscopy of the pagetoid spread of germ cell carcinoma in the rete testis: Morphologic evidence suggestive of field effect as a mechanism of tumor spread", APPL IMMUNO, 9(4), 2001, pp. 335-339
50. de Witte, H; van den Hurk, M; Sweep, F; Benraad, T; Geurts-Moespot, A; Ruiter, D; Verhofstad, A
    Development of quality control preparations for immunocytochemical assessment of urokinase-type plasminogen activator
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    H. de Witte et al., "Development of quality control preparations for immunocytochemical assessment of urokinase-type plasminogen activator", APPL IMMUNO, 9(3), 2001, pp. 281-287
51. Kuramochi, M; Fukuhara, H; Nobukuni, T; Kanbe, T; Maruyama, T; Ghosh, HP; Pletcher, M; Isomura, M; Onizuka, M; Kitamura, T; Sekiya, T; Reeves, RH; Murakami, Y
    TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer
    NATURE GENETICS
    
    M. Kuramochi et al., "TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer", NAT GENET, 27(4), 2001, pp. 427-430
52. Toschi, E; Barillari, G; Sgadari, C; Bacigalupo, I; Cereseto, A; Carlei, D; Palladino, C; Zietz, C; Leone, P; Sturzl, M; Butto, S; Cafaro, A; Monini, P; Ensoli, B
    Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor
    MOLECULAR BIOLOGY OF THE CELL
    
    E. Toschi et al., "Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor", MOL BIOL CE, 12(10), 2001, pp. 2934-2946
53. Harari, PM; Huang, SM
    Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling
    SEMINARS IN RADIATION ONCOLOGY
    
    P.M. Harari e S.M. Huang, "Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling", SEM RAD ONC, 11(4), 2001, pp. 281-289
54. Marti, U; Ruchti, C; Kampf, J; Thomas, GA; Williams, ED; Peter, HJ; Gerber, H; Burgi, U
    Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues
    THYROID
    
    U. Marti et al., "Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues", THYROID, 11(2), 2001, pp. 137-145
55. Berry, KK; Varney, ML; Dave, BJ; Bucana, CD; Fidler, IJ; Singh, RK
    Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    
    K.K. Berry et al., "Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines", INT J GYN C, 11(1), 2001, pp. 54-60
56. Davidson, JM
    Experimental animal wound models
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
    
    J.M. Davidson, "Experimental animal wound models", WOUNDS, 13(1), 2001, pp. 9-23
57. Negri, DRM; Mezzanzanica, D; Sacco, S; Gadina, M; Benigni, F; Cajola, L; Finocchiaro, G; Ghezzi, P; Canevari, S
    Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours
    CYTOKINE
    
    D.R.M. Negri et al., "Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours", CYTOKINE, 15(1), 2001, pp. 27-38
58. Kawashiri, S; Kojima, K; Kumagai, S; Nakagawa, K; Yamamoto, E
    Effects of chemotherapy on invasion and metastasis of oral cavity cancer in mice
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    
    S. Kawashiri et al., "Effects of chemotherapy on invasion and metastasis of oral cavity cancer in mice", HEAD NECK, 23(9), 2001, pp. 764-771
59. Khurana, D; Martin, EA; Kasperbauer, JL; O'Malley, BW; Salomao, DR; Chen, LP; Strome, SE
    Characterization of a spontaneously arising murine squamous cell carcinoma(SCC VII) as a prerequisite for head and neck cancer immunotherapy
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    
    D. Khurana et al., "Characterization of a spontaneously arising murine squamous cell carcinoma(SCC VII) as a prerequisite for head and neck cancer immunotherapy", HEAD NECK, 23(10), 2001, pp. 899-906
60. Tsai, SW; Li, L; Williams, LE; Anderson, AL; Raubitschek, A; Shively, JE
    Metabolism and renal clearance of In-111-labeled DOTA-conjugated antibody fragments
    BIOCONJUGATE CHEMISTRY
    
    S.W. Tsai et al., "Metabolism and renal clearance of In-111-labeled DOTA-conjugated antibody fragments", BIOCONJ CHE, 12(2), 2001, pp. 264-270
61. Gordon, EM; Zhu, NL; Prescott, MF; Chen, ZH; Anderson, WF; Hall, FL
    Lesion-targeted injectable vectors for vascular restenosis
    HUMAN GENE THERAPY
    
    E.M. Gordon et al., "Lesion-targeted injectable vectors for vascular restenosis", HUM GENE TH, 12(10), 2001, pp. 1277-1287
62. Vincenzi, B; Finolezzi, E; Fossati, C; Verzi, A; Santini, D; Tonini, G; Arullani, A; Avvisati, G
    Unusual presentation of Hodgkin's disease mimicking inflammatory bowel disease
    LEUKEMIA & LYMPHOMA
    
    B. Vincenzi et al., "Unusual presentation of Hodgkin's disease mimicking inflammatory bowel disease", LEUK LYMPH, 42(3), 2001, pp. 521-526
63. Otsuki, T; Yamada, O; Kurebayashi, J; Sakaguchi, H; Yata, K; Uno, M; Oka, T; Yawata, Y; Ueki, A
    Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells
    LEUKEMIA & LYMPHOMA
    
    T. Otsuki et al., "Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells", LEUK LYMPH, 41(3-4), 2001, pp. 397-409
64. Kim, ES; Khuri, FR; Herbst, RS
    Epidermal growth factor receptor biology (IMC-C225)
    CURRENT OPINION IN ONCOLOGY
    
    E.S. Kim et al., "Epidermal growth factor receptor biology (IMC-C225)", CURR OPIN O, 13(6), 2001, pp. 506-513
65. Inoue, K; Wood, CG; Slaton, JW; Karashima, T; Sweeney, P; Dinney, CPN
    Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8
    ONCOLOGY REPORTS
    
    K. Inoue et al., "Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8", ONCOL REP, 8(5), 2001, pp. 955-964
66. Izawa, JI; Slaton, JW; Kedar, D; Karashima, T; Perrotte, P; Czerniak, B; Grossman, HB; Dinney, CPN
    Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder
    ONCOLOGY REPORTS
    
    J.I. Izawa et al., "Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder", ONCOL REP, 8(1), 2001, pp. 9-15
67. Yunmbam, MK; Wellstein, A
    The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo
    ONCOLOGY REPORTS
    
    M.K. Yunmbam e A. Wellstein, "The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo", ONCOL REP, 8(1), 2001, pp. 161-164
68. Furihata, T; Sakai, T; Kawamata, H; Omotehara, F; Shinagawa, Y; Imura, J; Ueda, Y; Kubota, K; Fujimori, T
    A new in vivo model for studying invasion and metastasis of esophageal squamous cell carcinoma
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    T. Furihata et al., "A new in vivo model for studying invasion and metastasis of esophageal squamous cell carcinoma", INT J ONCOL, 19(5), 2001, pp. 903-907
69. Ahn, KS; Jung, YS; Kim, J; Lee, H; Yoon, SS
    Behavior of murine renal carcinoma cells crown in ectopic or orthotopic sites in syngeneic mice
    TUMOR BIOLOGY
    
    K.S. Ahn et al., "Behavior of murine renal carcinoma cells crown in ectopic or orthotopic sites in syngeneic mice", TUMOR BIOL, 22(3), 2001, pp. 146-153
70. Li, Y; Tang, ZY; Ye, SL; Liu, YK; Chen, J; Xue, Q; Chen, J; Gao, DM; Bao, WH
    Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97
    WORLD JOURNAL OF GASTROENTEROLOGY
    
    Y. Li et al., "Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97", WORLD J GAS, 7(5), 2001, pp. 630-636
71. Schuhmacher, J; Klivenyi, G; Kaul, S; Henze, M; Matys, R; Hauser, H; Clorius, J
    Pretargeting of human mammary carcinoma xenografts with bispecific anti-MUC1/anti-Ga chelate antibodies and immunoscintigraphy with PET
    NUCLEAR MEDICINE AND BIOLOGY
    
    J. Schuhmacher et al., "Pretargeting of human mammary carcinoma xenografts with bispecific anti-MUC1/anti-Ga chelate antibodies and immunoscintigraphy with PET", NUCL MED BI, 28(7), 2001, pp. 821-828
72. Downer, JB; Jones, LA; Katzenellenbogen, JA; Welch, MJ
    Effect of administration route on FES uptake into MCF-7 tumors
    NUCLEAR MEDICINE AND BIOLOGY
    
    J.B. Downer et al., "Effect of administration route on FES uptake into MCF-7 tumors", NUCL MED BI, 28(4), 2001, pp. 397-399
73. de Murphy, CA; Pedraza-Lopez, M; Ferro-Flores, G; Murphy-Stack, E; Chavez-Mercado, L; Ascencio, JA; Garcia-Salinas, L; Hernandez-Gutierrez, S
    Uptake of Re-188-beta-naphthyl-peptide in cervical carcinoma tumours in athymic mice
    NUCLEAR MEDICINE AND BIOLOGY
    
    C.A. de Murphy et al., "Uptake of Re-188-beta-naphthyl-peptide in cervical carcinoma tumours in athymic mice", NUCL MED BI, 28(3), 2001, pp. 319-326
74. Lindegren, S; Andersson, H; Back, T; Jacobsson, L; Karlsson, B; Skarnemark, G
    High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate
    NUCLEAR MEDICINE AND BIOLOGY
    
    S. Lindegren et al., "High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate", NUCL MED BI, 28(1), 2001, pp. 33-39
75. Andrei, G; Snoeck, R; Schols, D; De Clercq, E
    Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positivecells
    ONCOLOGY RESEARCH
    
    G. Andrei et al., "Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positivecells", ONCOL RES, 12(9-10), 2001, pp. 397-408
76. Fedorow, C; McGann, LE; Korbutt, GS; Rayat, GR; Rajotte, RV; Lakey, JRT
    Osmotic and cryoprotectant permeation characteristics of islet cells isolated from the newborn pig pancreas
    CELL TRANSPLANTATION
    
    C. Fedorow et al., "Osmotic and cryoprotectant permeation characteristics of islet cells isolated from the newborn pig pancreas", CELL TRANSP, 10(7), 2001, pp. 651-659
77. Miyamoto, M; Balamurugan, AN; Nozawa, Y; Sakurai, T; Xu, BY; Yoshimura, S; Tanaka, T; Tohyama, T; Miyakoshi, J; Inoue, K
    Development of a cryopreservation procedure employing a freezer bag for pancreatic islets using a newly developed cryoprotectant
    CELL TRANSPLANTATION
    
    M. Miyamoto et al., "Development of a cryopreservation procedure employing a freezer bag for pancreatic islets using a newly developed cryoprotectant", CELL TRANSP, 10(4-5), 2001, pp. 363-371
78. Tuch, BE; Tabiin, MT; Casamento, FM; Yao, M; Georges, P; Amaratunga, A; Pinto, AN
    Role of pancreatic polypeptide as a market of transplanted insulin-producing fetal pig cells
    CELL TRANSPLANTATION
    
    B.E. Tuch et al., "Role of pancreatic polypeptide as a market of transplanted insulin-producing fetal pig cells", CELL TRANSP, 10(3), 2001, pp. 285-293
79. Anderson, E
    Ovarian steroids and control of proliferation in the normal human breast
    BREAST
    
    E. Anderson, "Ovarian steroids and control of proliferation in the normal human breast", BREAST, 10(4), 2001, pp. 273-278
80. Ali, SH; O'Donnell, AL; Balu, D; Pohl, MB; Seyler, MJ; Mohamed, S; Mousa, S; Dandona, P
    High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors
    CELL PROLIFERATION
    
    S.H. Ali et al., "High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors", CELL PROLIF, 34(4), 2001, pp. 223-231
81. Kragh, M; Quistorff, B; Kristjansen, PEG
    Quantitative estimates of angiogenic and anti-angiogenic activity by laserDoppler flowmetry (LDF) and near infra-red spectroscopy (NIRS)
    EUROPEAN JOURNAL OF CANCER
    
    M. Kragh et al., "Quantitative estimates of angiogenic and anti-angiogenic activity by laserDoppler flowmetry (LDF) and near infra-red spectroscopy (NIRS)", EUR J CANC, 37(7), 2001, pp. 924-929
82. Kido, S; Kitadai, Y; Hattori, N; Haruma, K; Kido, T; Ohta, M; Tanaka, S; Yoshihara, M; Sumii, K; Ohmoto, Y; Chayama, K
    Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas?
    EUROPEAN JOURNAL OF CANCER
    
    S. Kido et al., "Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas?", EUR J CANC, 37(12), 2001, pp. 1482-1487
83. Baselga, J
    The EGFR as a target for anticancer therapy - focus on cetuximab
    EUROPEAN JOURNAL OF CANCER
    
    J. Baselga, "The EGFR as a target for anticancer therapy - focus on cetuximab", EUR J CANC, 37, 2001, pp. S16-S22
84. Chatzistamou, I; Schally, AV; Varga, JL; Groot, K; Busto, R; Armatis, P; Halmos, G
    Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
    ANTI-CANCER DRUGS
    
    I. Chatzistamou et al., "Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone", ANTI-CANC D, 12(9), 2001, pp. 761-768
85. Terwogt, JMM; Huinink, WWT; Schellens, JHM; Schot, M; Mandjes, IAM; Zurlo, MG; Rocchetti, M; Rosing, H; Koopman, FJ; Beijnen, JH
    Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel
    ANTI-CANCER DRUGS
    
    J.M.M. Terwogt et al., "Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel", ANTI-CANC D, 12(4), 2001, pp. 315-323
86. Arencibia, JM; Schally, AV; Halmos, G; Nagy, A; Kiaris, H
    In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses
    ANTI-CANCER DRUGS
    
    J.M. Arencibia et al., "In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses", ANTI-CANC D, 12(1), 2001, pp. 71-78
87. Huang, PS; Oliff, A
    Drug-targeting strategies in cancer therapy
    CURRENT OPINION IN GENETICS & DEVELOPMENT
    
    P.S. Huang e A. Oliff, "Drug-targeting strategies in cancer therapy", CUR OP GEN, 11(1), 2001, pp. 104-110
88. Itoi, M; Kawamoto, H; Katsura, Y; Amagai, T
    Two distinct steps of immigration of hematopoietic progenitors into the early thymus anlage
    INTERNATIONAL IMMUNOLOGY
    
    M. Itoi et al., "Two distinct steps of immigration of hematopoietic progenitors into the early thymus anlage", INT IMMUNOL, 13(9), 2001, pp. 1203-1211
89. Wolczynski, S; Surazynski, A; Swiatecka, J; Palka, J
    Estrogenic and antiestrogenic effects of raloxifene on collagen metabolismin breast cancer MCF-7 cells
    GYNECOLOGICAL ENDOCRINOLOGY
    
    S. Wolczynski et al., "Estrogenic and antiestrogenic effects of raloxifene on collagen metabolismin breast cancer MCF-7 cells", GYNECOL END, 15(3), 2001, pp. 225-233
90. Daniel, L; Durbec, P; Gautherot, E; Rouvier, E; Rougon, G; Figarella-Branger, D
    A nude mice model of human rhabdomyosarcoma lung metastases for evaluatingthe role of polysialic acids in the metastatic process
    ONCOGENE
    
    L. Daniel et al., "A nude mice model of human rhabdomyosarcoma lung metastases for evaluatingthe role of polysialic acids in the metastatic process", ONCOGENE, 20(8), 2001, pp. 997-1004
91. Sibley, K; Cuthbert-Heavens, D; Knowles, MA
    Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma
    ONCOGENE
    
    K. Sibley et al., "Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma", ONCOGENE, 20(6), 2001, pp. 686-691
92. Zou, CP; Youssef, EM; Zou, CC; Carey, TE; Lotan, R
    Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells
    ONCOGENE
    
    C.P. Zou et al., "Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells", ONCOGENE, 20(47), 2001, pp. 6820-6827
93. Jiang, YX; Cui, L; Yie, TA; Rom, WN; Cheng, H; Tchou-Wong, KM
    Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by I kappa B beta
    ONCOGENE
    
    Y.X. Jiang et al., "Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by I kappa B beta", ONCOGENE, 20(18), 2001, pp. 2254-2263
94. Nozaki, S; Sledge, GW; Nakshatri, H
    Repression of GADD153/CHOP by NF-kappa B: a possible cellular defense against endoplasmic reticulum stress-induced cell death
    ONCOGENE
    
    S. Nozaki et al., "Repression of GADD153/CHOP by NF-kappa B: a possible cellular defense against endoplasmic reticulum stress-induced cell death", ONCOGENE, 20(17), 2001, pp. 2178-2185
95. Guo, ML; Guo, ZJ; Sadler, PJ
    Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    
    M.L. Guo et al., "Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride", J BIOL I CH, 6(7), 2001, pp. 698-707
96. Heinzerling, LM; Feige, K; Rieder, S; Akens, MK; Dummer, R; Stranzinger, G; Moelling, K
    Tumor regression induced by intratumoral injection of DNA coding for humaninterleukin 12 into melanoma metastases in gray horses
    JOURNAL OF MOLECULAR MEDICINE-JMM
    
    L.M. Heinzerling et al., "Tumor regression induced by intratumoral injection of DNA coding for humaninterleukin 12 into melanoma metastases in gray horses", J MOL MED-J, 78(12), 2001, pp. 692-702
97. Bindels, EMJ; Vermey, M; De Both, NJ; van der Kwast, TH
    Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    E.M.J. Bindels et al., "Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines", VIRCHOWS AR, 439(4), 2001, pp. 552-559
98. Lohr, M; Muller, P; Zauner, I; Schmidt, C; Trautmann, B; Thevenod, F; Capella, G; Farre, A; Liebe, S; Jesnowski, R
    Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    M. Lohr et al., "Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras", VIRCHOWS AR, 438(6), 2001, pp. 581-590
99. Mostafavi-Pour, Z; Askari, JA; Whittard, JD; Humphries, MJ
    Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in celladhesion to fibronectin splice variants
    MATRIX BIOLOGY
    
    Z. Mostafavi-Pour et al., "Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in celladhesion to fibronectin splice variants", MATRIX BIOL, 20(1), 2001, pp. 63-73
100. de Groot, FMH; Damen, EWP; Scheeren, HW
     Anticancer prodrugs for application in monotherapy: Targeting hypoxia, tumor-associated enzymes, and receptors
     CURRENT MEDICINAL CHEMISTRY
     
     F.M.H. de Groot et al., "Anticancer prodrugs for application in monotherapy: Targeting hypoxia, tumor-associated enzymes, and receptors", CURR MED CH, 8(9), 2001, pp. 1093-1122